Abstract
The binding of 3H-cis flupenthixol (3H-FPT) to dopamine receptors in membrane preparations from control subjects and schizophrenics was studied. Using a fixed concentration of 3H-FPT, no differences were observed between controls and all schizophrenics, although 3H-FPT binding was increased in schizophrenics who apparently were drug-free at the time of death. Scatchard analysis of 3H-FPT binding revealed that in drug-treated schizophrenics both the number of binding sites (BM) and the dissociation constant (KD) were increased, whilst in drug-free schizophrenics only the BM was increased. Using domperidone to differentiate 3H-FPT binding to D1 and D2 dopamine sites, it was found that only D2 sites were increased in drug-free schizophrenics. The results are discussed with reference to previous studies on dopamine receptors in schizophrenia, and the effects of neuroleptic treatment. It is suggested that a selective increase in D2 receptors may be associated with the disease process in schizophrenia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bird ED, Crow TJ, Iversen LL, Longden A, Mackay AVP, Riley GJ, Spokes EG (1979) Dopamine and homovanillic acid concentrations in the post-mortem brains of schizophrenics. J Physiol (Lond) 293:36–37P
Bjerkenstedt L, Harnyd C, Sedvall G (1979) Effects of sulpiride on monoaminergic mechanisms in psychotic women. Psychopharmacology 64:135–139
Bowers MB (1974) Central dopamine turnover in schizophrenic syndromes. Arch Gen Psychiatry 31:50–54
Carenzi A, Gillin C, Guidotti A, Schwartz M, Trabucchi M, Wyatt RJ (1975) Dopamine-sensitive adenylate cyclase in human caudate nucleus. Arch Gen Psychiatry 32:1056–1059
Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481–482
Cross AJ, Owen F (1980) Characteristics of 3H-cis flupenthixol binding to calf brain membranes. Eur J Pharmacol 65:341–347
Cross AJ, Crow TJ, Killpack WS, Longden A, Owen F, Riley GJ (1978) The activities of dopamine-β-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls. Psychopharmacology 59:117–121
Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Munoz R (1972) Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26:57–63
Hyttel J (1978) Effects of neuroleptics on 3H-haloperidol and 3H-cis (Z)-flupenthixol binding and on adenylate cyclase activity in vitro. Life Sci 23:551–556
Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93–96
Laduron PM, Leysen JE (1979) Domperidone, a specific in vitro dopamine antagonist devoid of in vivo central dopaminergic activity. Biochem Pharmacol 28:2161–2165
Lee T, Seeman P, Tourtellotte WW, Farley IJ, Hornykeiwicz O (1978) Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains. Nature 274:897–900
List S, Titeler M, Seeman P (1980) High affinity 3H-dopamine receptors (D3 sites) in human and rat brain. Biochem Pharmacol 29:1621–1622
Marsden CD, Jenner P (1980) The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med 10:55–72
Moller-Nielsen I, Boeck V, Christensen AV, Danniskiold-Samsoe P, Hyttel J, Langelund V, Pedersen V, Svendson O (1977) The pharmacology of a new potent long acting neuroleptic, piflutixol. Acta Pharmacol Toxicol 41:369–383
Owen F, Cross AJ, Crow TJ, Longden A, Poulter M, Riley GJ (1978) Increased dopamine receptor sensitivity in schizophrenia. Lancet (ii):223–225
Owen F, Cross AJ, Poulter M, Waddington JL (1979) Change in the characteristics of 3H-spiperone binding to rat striatal membranes after acute chlorpromazine administration: effects of buffer washing of membranes. Life Sci 25:385–390
Owen F, Cross AJ, Crow TJ, Lofthouse R, Poulter M (1981) Neurotransmitter receptors in brain in schizophrenia. Acta Psychiatr Scand 63 (Suppl 291):20–27
Randrup A, Mukvad I (1967) Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia 11:300–310
Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672
Seeman P, Lee T, Chau-Wong M, Wong K (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261:717–719
Snyder SH, Goodman RR (1980) Multiple neurotransmitter receptors. J Neurochem 35:5–15
Sutherland EW, Cori CF, Haynes R, Olsen NS (1949) Purification of hyperglycemic-glycogenolytic factor from insulin and from gastric mucosa. J Biol Chem 180:825–837
Watling KJ, Dowling JE, Iversen LL (1979) Dopamine receptors in the retina may all be linked to adenylate cyclase. Nature 281:518–519
Wing JK, Cooper JE, Sartorius N (1974) Measurement and classification of psychiatric symptoms. Cambridge University Press, London
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cross, A.J., Crow, T.J. & Owen, F. 3H-flupenthixol binding in post-mortem brains of schizophrenics: Evidence for a selective increase in dopamine D2 receptors. Psychopharmacology 74, 122–124 (1981). https://doi.org/10.1007/BF00432676
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00432676